| ID | 1506 | |
| PMID | 15603887 | |
| Year | 2005 | |
| Sequence | APQIVRGASEDVRK QPYNLTIAWFRMGG | |
| Name | gD 77-104 (group 1) | |
| Length | 28 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Linear | |
| Chirality | L | |
| Chemical Modification | None | |
| Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
| Nature of Peptide/Cargo | not mentioned | |
| Mechanism | T-cell epitope peptide identified from HSV1-gD | |
| Cargo Sequence/Structure | None | |
| Name of cargo | Not applicable | |
| Assay | ELISA, Antibody assay, Peptide specific T-cell assays | |
| Enhancer | PBS (pH 7.3). | |
| Properties of enhancer | Not mentioned | |
| Concentration | 25ul | |
| Incubation time | 21 days | |
| Tissue permeability (value with units) | Failed to induce significant IgA titers (p > 1). | |
| Tissue Sample | eye | |
| Ex vivo/In vivo/In vitro | in vivo | |
| STRUCTURE |
| |
| SMILES | N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC=O) CCSC)CCCNC(=N)N)Cc2ccccc2)Cc2c[nH]c3c2cccc3)C)[C@H] (CC)C)[C@H](O)C)CC(C)C)CC(=O)N)Cc2ccc(cc2)O) CCC)CCC(=O)N)CCCCN)CCCNC(=N)N)C(C)C)CC(=O)O)CCC(=O) O)CO)C)CCCNC(=N)N)C(C)C)[C@H](CC)C)CCC(=O)N)CCC1)C | |